October 2017

Team of scientists at iMed.ULisboa developed a new strategy to cancer-cell-targeting

A team of scientists lead by Pedro Góis, leader from Bioorganic Chemistry  group at iMed.ULisboa developed a new strategy to prepare cancer-cell-targeting drug conjugates that explore boron modularity to increase the conjugate valence, potency and selectivity for folate-positive MDA-MB-231 cancer cells.

More information at Angewandte Chemie International Edition